Carcinoma of unknown primary site--a complete and sustained response with interleukin-2, alpha interferon and 5-fluorouracil/leucovorin.
Dave
H P
HP
Mount Vernon Cancer Institute, Alexandria, VA 22306.
White
C L
CL
Schulof
R
R
Avis
F P
FP
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D007375:Interleukin-1 / Q000008:administration & dosage; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy*
D016898:Interferon-alpha; D007375:Interleukin-1; D002955:Leucovorin; D005472:Fluorouracil